Reserpine labels and packages

Reserpine
Reserpine® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Reserpine
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

Labels And Packages

0.1 mg Label

NDC 0185-0032-01

Reserpine

Tablets, USP

0.1 mg

Rx only

100 Tablets

Sandoz

[[image:reserpine2.jpg|400px|thumb]

0.25 mg Label

NDC 0185-0134-01

Reserpine

Tablets, USP

0.25 mg

Rx only

100 Tablets

Sandoz